Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

9431 ARTÍCULOS , VIENDO DEL 4306 AL 4320

Alternative Splicing of Alpha- and Beta-Synuclein Genes Plays Differential Roles in Synucleinopathies

Gámez-Valero A, Beyer K.

Genes (Basel). 2018 Jan 25;9(2):63. doi: 10.3390/genes9020063.

Features of GBA-associated Parkinson's disease at presentation in the UK Tracking Parkinson's study

Malek N, Weil RS, Bresner C, Lawton MA, Grosset KA, Tan M, Bajaj N, Barker RA, Burn DJ, Foltynie T, Hardy J, Wood NW, Ben-Shlomo Y, Williams NW, Grosset DG, Morris HR; PRoBaND clinical consortium.

J Neurol Neurosurg Psychiatry. 2018 Jul;89(7):702-709. doi: 10.1136/jnnp-2017-317348. Epub 2018 Jan 29.

99mTc-TRODAT-1 SPECT/CT imaging as a complementary biomarker in the diagnosis of parkinsonian syndromes

Mittal BR, Sood A, Shukla J, Vatsa R, Bhusari P, Shree R, Mehta S, Goyal M, Modi M.

Nucl Med Commun. 2018 Apr;39(4):312-318. doi: 10.1097/MNM.0000000000000802.

Bilateral subthalamic deep brain stimulation initial impact on nonmotor and motor symptoms in Parkinson's disease: An open prospective single institution study

Kurcova S, Bardon J, Vastik M, Vecerkova M, Frolova M, Hvizdosova L, Nevrly M, Mensikova K, Otruba P, Krahulik D, Kurca E, Sivak S, Zapletalova J, Kanovsky P.

Medicine (Baltimore). 2018 Feb;97(5):e9750. doi: 10.1097/MD.0000000000009750.

New Developments in Genetic rat models of Parkinson's Disease

Creed RB, Goldberg MS.

Mov Disord. 2018 May;33(5):717-729. doi: 10.1002/mds.27296. Epub 2018 Feb 8.

[New Diagnostic Criteria for Parkinson's Disease: MDS-PD Criteria]

Watanabe H, Hara K, Ito M, Katsuno M, Sobue G.

Brain Nerve. 2018 Feb;70(2):139-146. doi: 10.11477/mf.1416200966.

Multitarget transcranial direct current stimulation for freezing of gait in Parkinson's disease

Dagan M, Herman T, Harrison R, Zhou J, Giladi N, Ruffini G, Manor B, Hausdorff JM.

Mov Disord. 2018 Apr;33(4):642-646. doi: 10.1002/mds.27300. Epub 2018 Feb 13.

Nigrostriatal dopamine transporter availability in early Parkinson's disease

Fazio P, Svenningsson P, Cselényi Z, Halldin C, Farde L, Varrone A.

Mov Disord. 2018 Apr;33(4):592-599. doi: 10.1002/mds.27316. Epub 2018 Feb 13.

[The new tremor classification of the International Parkinson and Movement Disorder Society : Update on frequent tremors]

Gövert F, Becktepe J, Deuschl G.

Nervenarzt. 2018 Apr;89(4):376-385. doi: 10.1007/s00115-018-0489-1.

Novel PLA2G6 mutations and clinical heterogeneity in Chinese cases with phospholipase A2-associated neurodegeneration

Chen YJ, Chen YC, Dong HL, Li LX, Ni W, Li HF, Wu ZY.

Parkinsonism Relat Disord. 2018 Apr;49:88-94. doi: 10.1016/j.parkreldis.2018.02.010. Epub 2018 Feb 9.

Progressive Supranuclear Palsy: an Update

Armstrong MJ.

Curr Neurol Neurosci Rep. 2018 Feb 17;18(3):12. doi: 10.1007/s11910-018-0819-5.

Lifetime exposure to estrogen and progressive supranuclear palsy: Environmental and Genetic PSP study

Park HK, Ilango S, Charriez CM, Checkoway H, Riley D, Standaert DG, Bordelon Y, Shprecher DR, Reich SG, Hall D, Kluger B, Marras C, Jankovic J, Dubinsky R, Litvan I; ENGENE-PSP Study.

Mov Disord. 2018 Mar;33(3):468-472. doi: 10.1002/mds.27336. Epub 2018 Feb 20.

Nonmotor symptoms evolution during 24 months of bilateral subthalamic stimulation in Parkinson's disease

Dafsari HS, Silverdale M, Strack M, Rizos A, Ashkan K, Mahlstedt P, Sachse L, Steffen J, Dembek TA, Visser-Vandewalle V, Evans J, Antonini A, Martinez-Martin P, Ray-Chaudhuri K, Timmermann L; EUROPAR and the IPMDS Non Motor PD Study Group.

Mov Disord. 2018 Mar;33(3):421-430. doi: 10.1002/mds.27283. Epub 2018 Feb 21.

Facial emotion recognition in Parkinson's disease: A review and new hypotheses

Argaud S, Vérin M, Sauleau P, Grandjean D.

Mov Disord. 2018 Apr;33(4):554-567. doi: 10.1002/mds.27305. Epub 2018 Feb 23.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias